At close: December 16 at 4:00:00 PM EST
After hours: December 16 at 6:54:12 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BORTHWICK KATHLEEN Chief Financial Officer | Sale | Feb 13, 2024 | 28,466 |
| CALE EDGAR B. General Counsel | Sale | Jan 2, 2024 | 45,995 |
| FORMAN MARK S M.D., PH.D. Officer | Sale | Feb 13, 2024 | 48,631 |
| FOTOPOULOS ALEXANDROS Chief Technology Officer | Sale | Jun 16, 2023 | 28,693 |
| KING SIMONA Chief Financial Officer | Conversion of Exercise of derivative security | Jul 28, 2023 | 23,994 |
| LYNX1 CAPITAL MANAGEMENT LP Beneficial Owner of more than 10% of a Class of Security | Purchase | Nov 27, 2024 | -- |
| ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale | Dec 11, 2024 | -- |
Related Tickers
DTIL Precision BioSciences, Inc.
4.7400
-12.87%
GBIO Generation Bio Co.
1.1600
0.00%
STOK Stoke Therapeutics, Inc.
12.24
+1.49%
PMVP PMV Pharmaceuticals, Inc.
1.5600
-1.27%
SPRO Spero Therapeutics, Inc.
1.0700
0.00%
GOSS Gossamer Bio, Inc.
0.8578
-7.76%
NKTX Nkarta, Inc.
2.3100
-1.28%
ANTX AN2 Therapeutics, Inc.
1.3500
-5.59%
ALEC Alector, Inc.
1.9800
+0.51%
ACET Adicet Bio, Inc.
0.9626
-0.23%